| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.283.11.1469 |
| P8608 | Fatcat ID | release_wy5pwi6nqnfcnban2p2yzm6afi |
| P3181 | OpenCitations bibliographic resource ID | 663211 |
| P698 | PubMed publication ID | 10732937 |
| P2093 | author name string | D T Felson | |
| T E McAlindon | |||
| M P LaValley | |||
| J P Gulin | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucosamine | Q32907954 |
| osteoarthritis | Q62736 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 1469-75 | |
| P577 | publication date | 2000-03-15 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | |
| P478 | volume | 283 |
| Q35128655 | ???Natural Remedies??? in the Treatment of Osteoarthritis |
| Q92155858 | A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis |
| Q36955387 | A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee |
| Q36075955 | A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals |
| Q36301591 | A longitudinal study of nonvitamin, nonmineral supplement use: prevalence, associations, and survival in an aging population |
| Q35770645 | A randomized comparative study of safety and efficacy of immediate release glucosamine HCL and glucosamine HCL sustained release formulation in the treatment of knee osteoarthritis: A proof of concept study |
| Q34122293 | A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee |
| Q35007384 | A review of articular cartilage pathology and the use of glucosamine sulfate |
| Q44302980 | A survey of self-medication practices and perceived effectiveness of glucosamine products among older adults |
| Q46602405 | Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial |
| Q35072852 | Advances in rheumatology: coxibs and beyond |
| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q24633869 | An empirical investigation of the potential impact of selective inclusion of results in systematic reviews of interventions: study protocol |
| Q36306651 | An overview of hip injuries in running |
| Q90548301 | Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis |
| Q51421445 | Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats. |
| Q34977910 | Articular Cartilage Injury in Athletes |
| Q43525281 | Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model |
| Q44638466 | Biochemical injection treatment for discogenic low back pain: a pilot study |
| Q35666160 | Biological basis for the benefit of nutraceutical supplementation in arthritis |
| Q24202794 | Bisphosphonates for osteoarthritis |
| Q34545778 | Carbohydrate engineered cells for regenerative medicine. |
| Q36245717 | Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q22000858 | Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study |
| Q24186473 | Chondroitin for osteoarthritis |
| Q24245297 | Chondroitin for osteoarthritis |
| Q34002078 | Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview |
| Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
| Q35042879 | Chondroitin sulphate inhibits connective tissue mast cells |
| Q34906145 | Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI |
| Q35196931 | Chondroprotective agents: glucosamine and chondroitin |
| Q34280879 | Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention |
| Q28212371 | Collagen Synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of Glucosamine HCl and chondroitin sulfate |
| Q36475626 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib |
| Q46367849 | Combined glucosamine and chondroitin sulfate provides functional and structural benefit in the anterior cruciate ligament transection model. |
| Q36675924 | Comparative efficacy and safety study of two chondroitin sulfate preparations from different origin (avian and bovine) in symptomatic osteoarthritis of the knee |
| Q82234503 | Compare the effects of chondrogenesis by culture of human mesenchymal stem cells with various type of the chondroitin sulfate C |
| Q21254655 | Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351] |
| Q33632751 | Comparison of glucose derivatives effects on cartilage degradation |
| Q84649749 | Complementary and Alternative Medicines: Clinical Pearls for Commonly Used Dietary Supplements |
| Q34235511 | Complementary and alternative therapies for rheumatic disease |
| Q30356453 | Complementary or alternative therapies for osteoarthritis. |
| Q35824619 | Conducting clinical trials over the internet: feasibility study. |
| Q36067679 | Considerations in the treatment of early osteoarthritis |
| Q59481265 | Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized |
| Q37706220 | D-Glucosamine supplementation extends life span of nematodes and of ageing mice |
| Q38856377 | DRUG THERAPY IN KNEE OSTEOARTHROSIS. |
| Q24653945 | Determination of chondroitin sulfate content in raw materials and dietary supplements by high-performance liquid chromatography with ultraviolet detection after enzymatic hydrolysis: single-laboratory validation |
| Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
| Q34536820 | Dietary supplements for football. |
| Q30235140 | Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment |
| Q39767735 | Digital X-ray radiogrammetry better identifies osteoarthritis patients with a low bone mineral density than quantitative ultrasound |
| Q38371965 | Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. |
| Q36055502 | Disease-modifying therapies for osteoarthritis : current status |
| Q34572300 | Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? |
| Q41982421 | Dual Function of Glucosamine in Gelatin/Hyaluronic Acid Cryogel to Modulate Scaffold Mechanical Properties and to Maintain Chondrogenic Phenotype for Cartilage Tissue Engineering |
| Q24674132 | EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) |
| Q31119321 | EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). |
| Q84448818 | Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI |
| Q44602669 | Effect of Brand's glucosamine with essence of chicken on collagen-induced arthritis in rats |
| Q35676918 | Effect of a blend of comfrey root extract (Symphytum officinale L.) and tannic acid creams in the treatment of osteoarthritis of the knee: randomized, placebo-controlled, double-blind, multiclinical trials |
| Q36230822 | Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study |
| Q73558500 | Effect of a topical herbal cream on osteoarthritis of the hand and knee: a pilot study |
| Q44533873 | Effect of chondroitin sulphate C on the in vitro and in vivo chondrogenesis of mesenchymal stem cells in crosslinked type II collagen scaffolds |
| Q34001775 | Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study |
| Q33313591 | Effect of combined laser acupuncture on knee osteoarthritis: a pilot study |
| Q40526468 | Effect of glucosamine on intraocular pressure: a randomized clinical trial. |
| Q35627520 | Effectiveness of intra-articular injections of sodium bicarbonate and calcium gluconate in the treatment of osteoarthritis of the knee: a randomized double-blind clinical trial |
| Q37398414 | Effects of AIF on Knee Osteoarthritis Patients: Double-blind, Randomized Placebo-controlled Study |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q78032713 | Effects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebo-controlled clinical evaluation |
| Q90178117 | Effects of dietary supplements on selected hematological and biochemical parameters of Pakistani athletes |
| Q54493171 | Effects of glucosamine administration on patients with rheumatoid arthritis. |
| Q35125975 | Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models |
| Q88528202 | Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q44525457 | Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage |
| Q43804474 | Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats |
| Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
| Q36517447 | Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study |
| Q92416265 | Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials |
| Q34605351 | Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review |
| Q33943890 | Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study |
| Q44660320 | Enzymatic Synthesis of Chondroitin and Its Derivatives Catalyzed by Hyaluronidase |
| Q24647595 | Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system |
| Q37204153 | Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study |
| Q36409280 | Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats |
| Q33847208 | Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double-blind placebo-controlled clinical study |
| Q46770338 | Evidence-based evaluation of study results of symptomatic glucosamine therapy |
| Q36603277 | Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis |
| Q35056506 | FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms |
| Q28215692 | GLUT2 is a high affinity glucosamine transporter |
| Q79319417 | Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend? |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q28360122 | Glucosamine and chondroitin may help in osteoarthritis |
| Q34656760 | Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis |
| Q57244851 | Glucosamine and chondroitin sulfate in knee osteoarthritis: where now? |
| Q24805719 | Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report |
| Q43090795 | Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro. |
| Q41176136 | Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro |
| Q21284705 | Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism |
| Q28366848 | Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works |
| Q33214439 | Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials |
| Q34534426 | Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes |
| Q24244026 | Glucosamine therapy for treating osteoarthritis |
| Q50057188 | Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort |
| Q37036372 | Glucosamine-containing supplement improves locomotor functions in subjects with knee pain - a pilot study of gait analysis |
| Q36244219 | Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study |
| Q55498592 | Glucosamine: A potential disease-modifying agent in osteoarthritis? |
| Q36918156 | Glucosamine: an ingredient with skin and other benefits |
| Q32050548 | Glusoamine for osteoarthritis: dawn of a new era? |
| Q54995051 | Glycosaminoglycans and Proteoglycans. |
| Q34576349 | Herbal and nonherbal supplements in medical-psychiatric patient populations |
| Q34974685 | Hip pain and mobility deficits--hip osteoarthritis: clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopaedic section of the American Physical Therapy Association. |
| Q58040371 | Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study |
| Q33994668 | Immunological activity of chondroitin sulfate |
| Q44102095 | Immunosuppressive effects of glucosamine |
| Q43090797 | In vitro study of the inhibition and induction of human cytochromes P450 by crystalline glucosamine sulfate. |
| Q47816389 | Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). |
| Q44832606 | Influence of irrigation solutions combined with colchicine and diclofenac sodium on articular cartilage in a rat model |
| Q33815355 | Integrative approaches to pain management: how to get the best of both worlds |
| Q40626602 | Interleukin-12 release from macrophages by hyaluronan, chondroitin sulfate A and chondroitin sulfate C oligosaccharides |
| Q37062477 | Intervertebral disc: anatomy-physiology-pathophysiology-treatment |
| Q97527844 | Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis |
| Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
| Q81382549 | Is treatment with chondroitin efficacious for osteoarthritis? |
| Q31046250 | Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative |
| Q32050561 | Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial |
| Q35636751 | Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness |
| Q42496279 | Managing osteoarthritis of the knee |
| Q35871489 | Mast cells and mast cell mediators as targets of dietary supplements |
| Q24799604 | Meta-analysis: neither quick nor easy |
| Q43108976 | Method for Delivering a Controlled Impact to Articular Cartilage in the Rabbit Knee |
| Q34303993 | Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis? |
| Q32066343 | New agents for the medical treatment of interstitial cystitis |
| Q46106832 | Non-surgical treatment of osteoarthritis of large joints - new aspects |
| Q35553761 | Non-surgical treatment of osteoarthritis: a half century of "advances". |
| Q36209436 | Nutraceutical therapies for degenerative joint diseases: a critical review. |
| Q37020227 | Nutrition for throwers, jumpers, and combined events athletes |
| Q34686551 | Nutritional genomics |
| Q36981763 | Nutritional supplements and conventional medicine; what should the physician know? |
| Q56032350 | Osteoarthritis |
| Q36085680 | Osteoarthritis - an untreatable disease? |
| Q21195656 | Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence |
| Q30863651 | Osteoarthritis of the knee |
| Q34976432 | Osteoarthritis: supplements and other alternative modalities |
| Q35740878 | PURLs: arthritis pain? These supplements provide little relief. |
| Q44778759 | Pharmacological interaction of glucosamine sulphate and acenocoumarol |
| Q33631650 | Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes |
| Q34112904 | Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes |
| Q93025858 | Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study) |
| Q36768159 | Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study |
| Q59083206 | Preparation and characterisation of vanadium complexes derived from salicylaldehyde or pyridoxal and sugar derivatives |
| Q38856700 | Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women |
| Q58912917 | Primer documento de consenso de la Sociedad Española de Reumatología sobre el tratamiento farmacológico de la artrosis de rodilla |
| Q35000443 | Prospective image registration for automated scan prescription of follow-up knee images in quantitative studies |
| Q37611121 | Quality of different chondroitin sulfate preparations in relation to their therapeutic activity |
| Q34630468 | Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis |
| Q33802220 | Recent advances: rheumatology |
| Q33802329 | Regular review: medical management of osteoarthritis |
| Q33803779 | Research into complementary and alternative medicine: problems and potential |
| Q37868846 | Review article: Osteochondral reconstruction and grafting. |
| Q34098905 | Rheumatology and musculoskeletal medicine |
| Q34570456 | Risk assessment for glucosamine and chondroitin sulfate |
| Q34423402 | Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. |
| Q34264613 | Role of glucosamine in the treatment for osteoarthritis |
| Q47147618 | Scientific Opinion on the substantiation of a health claim related to glucosamine hydrochloride and reduced rate of cartilage degeneration and reduced risk of development of osteoarthritis pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| Q42135777 | Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties |
| Q53567904 | Sensitive and rapid analytical method for the quantification of glucosamine in human plasma by ultra high performance liquid chromatography with tandem mass spectrometry. |
| Q36406090 | Short report: ibuprofen versus glucosamine sulfate. Treating osteoarthritis pain |
| Q51652992 | Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods. |
| Q34003218 | Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort |
| Q36067671 | State-of-the-art disease-modifying osteoarthritis drugs |
| Q36527599 | Supplements and injections for joint disease |
| Q39044794 | Suppressive effects of D-glucosamine on the 5-HT sensitive nociceptive units in the rat tooth pulpal nerve |
| Q34789324 | Sweet solution: sugars to the rescue |
| Q64923946 | Symptoms-modifying effects of electromotive administration of glucosamine sulphate among patients with knee osteoarthritis. |
| Q34402862 | Synergy between medical and nutrient therapies: George Washington meets Rodney Dangerfield |
| Q37992137 | Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis |
| Q37596611 | Targeting subchondral bone for treating osteoarthritis: what is the evidence? |
| Q37603698 | Temporomandibular joint osteoarthritis: diagnosis and long-term conservative management: a topic review |
| Q33622337 | The Hip and Knee Book: developing an active management booklet for hip and knee osteoarthritis |
| Q24630475 | The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial |
| Q24799688 | The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166]. |
| Q37933356 | The effect on comorbidity and pain in patients with osteoarthritis |
| Q37667284 | The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial |
| Q36765477 | The horse as a model of naturally occurring osteoarthritis |
| Q34729786 | The placebo effect and randomized trials: analysis of alternative medicine |
| Q37049693 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37154872 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37228620 | The potential of chondroitin sulfate as a therapeutic agent |
| Q59797962 | The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials |
| Q36719696 | The reverse glucosamine sulfate pathway: application in knee osteoarthritis |
| Q37020249 | The use of dietary supplements by athletes |
| Q45127723 | The use of glucosamine therapy in osteoarthritis |
| Q35624596 | The use of glucosamine therapy in osteoarthritis |
| Q36793235 | The utility of nutraceuticals in the treatment of osteoarthritis |
| Q82328978 | Therapy for osteoarthritis in the horse - how do we know that it works? |
| Q46905515 | Thermal and storage stability of nutraceuticals in a milk beverage dietary supplement |
| Q33849348 | Total mortality risk in relation to use of less-common dietary supplements |
| Q43709029 | Transcriptional engineering of Escherichia coli K4 for fructosylated chondroitin production |
| Q54193159 | Transdermal Permeability of N-Acetyl-D-Glucosamine |
| Q37762660 | Treatment of glenohumeral arthrosis. |
| Q36713906 | Treatment of knee osteoarthritis with oral chondroitin sulfate |
| Q37858371 | Treatment options for osteoarthritis: considerations for older adults |
| Q33323179 | Update in pain medicine |
| Q34473924 | Use of complementary and alternative medicine in pediatric pain management service: a survey |
| Q35554070 | Use of complementary medicines for osteoarthritis--a prospective study |
| Q35220305 | Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort |
| Q36900371 | Use of glucosamine and chondroitin supplements and risk of colorectal cancer. |
| Q39644887 | Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study |
| Q91867823 | Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature |
| Q24657307 | Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States |
| Q64933398 | Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. |
| Q44650052 | Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis |
| Q34439681 | What a difference a year makes: reflections on the ACR recommendations for the medical management of osteoarthritis |
| Q35578049 | What is important in treating osteoarthritis? Whom should we treat and how should we treat them? |
| Q31080416 | Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older |
| Q35578069 | Why are clinical trials of glucosamine no longer uniformly positive? |
| Q84600034 | [Current therapeutic approach osteoarthritis] |
| Q88336488 | [Pharmacological treatment of osteoarthritis-related pain] |
| Q53448367 | [The management of osteoarthritis by general practitioners in Germany: comparison of self-reported behaviour with international guidelines]. |
Search more.